☆ 4.7 Editorial Material

GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Volume -, Issue -, Pages -

Publisher

ENDOCRINE SOC

DOI: 10.1210/clinem/dgac704

Keywords

GLP-1 receptor agonists; SGLT2 inhibitors; type 1 diabetes; real-world outcomes; safety; efficacy

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.